Akèy › Kansè (tout kalite) › North Carolina › Charlotte
Etid klinik pou Kansè (tout kalite) nan Charlotte, NC
27 etid pou Kansè (tout kalite) ap chèche patisipan nan sit nan ak bò kote Charlotte (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Registry Study for Radiation Therapy Outcomes
Ap rekriteEtid obsèvasyon
- Atrium Health Levine Cancer Proton & Advanced Radiation Center, Charlotte
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Ap rekriteFaz 2/3
- Levine Cancer Institute, Charlotte
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Ap rekriteFaz 1
- Levine Cancer Institute, Charlotte
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
Ap rekriteFaz 2
- Atrium Health's Levine Cancer Institute, Charlotte
Long-Term Follow-up Protocol for Participants Treated With Gene-Modified T Cells
Ap rekriteFaz 2/3
- Levine Cancer Institute, Charlotte
A Study to Assess Adverse Events and Change in Disease Activity of Oral Surzetoclax Alone or in Combination With Subcutaneous and/or Oral Antimyeloma Agents in Adult Participants With Multiple Myeloma (MM)
Ap rekriteFaz 1/2
- Atrium Health Levine Cancer Institute /ID# 271510, Charlotte
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
Ap rekriteFaz 1/2
- Research Site, Charlotte
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Ap rekriteFaz 2
- Oncology Specialists of Charlotte, Charlotte
- Southern Oncology Specialists, Huntersville · 13 mi lwen
Comprehensive Care for AYA: Needs Assessment Survey
Ap rekriteEtid obsèvasyon
- Atrium Health Levine Cancer, Charlotte
A Study of ARC-02 in B-cell NHL
Ap rekriteFaz 1
- Levine Cancer Institute, Charlotte
Project: Every Child for Younger Patients With Cancer
Ap rekriteEtid obsèvasyon
- Carolinas Medical Center/Levine Cancer Institute, Charlotte
- Novant Health Presbyterian Medical Center, Charlotte
Role of Mitochondrial Bioenergetics in Resilience for Gynecologic Cancer
Ap rekriteEtid obsèvasyon
- Atrium Health Levine Cancer, Charlotte
A Single-arm, Phase II Clinical Trial of ASPIRin to prEvent Venous Thromboembolism in Patients With Advanced Germ Cell Tumors Receiving Chemotherapy
Ap rekriteFaz 2
- Atrium Health Wake Forest Baptist Comprehensive Cancer Center, Charlotte
Patient Descriptors Of Cancer-Related Fatigue: A Mixed Methods Pilot Study Of Cancer Survivors
Ap rekriteEtid obsèvasyon
- Levine Childrens Hospital Pediatric Cancer and Blood Disorders, Charlotte
- Levine Cancer Institute, Charlotte
Immune Function and Response to Vaccination After Cancer Therapy in Pediatric Patients
Ap rekriteFaz 2
- Levine Cancer Institute, Charlotte
LCI-PED-NOS-EXER-001: Exercise in Pediatric Oncology Patients
Ap rekrite
- Levine Children's Hospital, Charlotte
A Study to Assess Change in Disease Activity and Adverse Events (AE)s in Adult Participants With Multiple Myeloma Receiving T Cell Engaging Bi/Tri-specific Antibodies Intravenously (IV)/Subcutaneously (SC) Alone or in Combinations
Ap rekriteFaz 1/2
- Atrium Health Levine Cancer Institute /ID# 276193, Charlotte
A Novel Dialectical Behavior Therapy Brief Group Intervention for Cigarette Smoking by Patients With Cancer: An Open Clinical Trial
Ap rekrite
- Atrium Health Levine Cancer, Charlotte
Resilience Enhancement Using Electronic Frailty Index-Directed Care Pathway
Ap rekrite
- Levine Cancer Institute, Charlotte
Phase 1/2 Study of ETX-636 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1/2
- Carolina BioOncology Institute, Huntersville · 13 mi lwen
Isa-Rd for Frail and/or Much Older Patients With Newly Diagnosed Multiple Myeloma
Ap rekriteFaz 2
- Levine Cancer Institute, Charlotte
Study to Assess Change in Disease Activity and Adverse Events of Oral Venetoclax With Intravenous (IV) Obinutuzumab in Adult Participants With Recurring Chronic Lymphocytic Leukemia (CLL)
Ap rekriteFaz 2
- Novant Health Presbyterian Medical Center /ID# 230201, Charlotte
A Phase 1 Study of JMT108 in Participants With Advanced Solid Tumors
Ap rekriteFaz 1
- Carolina BioOncology Institute, Huntersville · 13 mi lwen
Trial of Nab-Sirolimus in Combination With Letrozole in Patients With Advanced or Recurrent Endometrioid Endometrial Cancer
Ap rekriteFaz 2
- Levine Cancer Institute, Charlotte
Open-Label, Dose-Escalation With Expansion to Assess the Safety, Tolerability, and PK of TRE-515 in Subjects With Solid Tumors
Ap rekriteFaz 1
- Carolina BioOncology Institute, Huntersville · 13 mi lwen
A Study for Participants Previously Treated With Century Therapeutics Cellular Therapy Product
Ap rekriteEtid obsèvasyon
- Levine Cancer Institute, Charlotte
A Prospective Real World Evidence Study (PROWES) for Concordance Rate of Blood-based 3D Genome Conformation Mapping (Episwitch CiRT®) to Identify Likelihood of Response and Actual Response Rates to PD-(L)-1 Checkpoint Inhibitors Across Multiple Oncological Indications.
Ap rekriteEtid obsèvasyon
- Carolina Blood and Cancer Care Associates, Rock Hill · 23 mi lwen
Etid Kansè (tout kalite) nan lòt vil
- Houston, TX121 etid
- New York City, NY109 etid
- Boston, MA85 etid
- Los Angeles, CA74 etid
- Nashville, TN65 etid
- Philadelphia, PA59 etid
- Washington, DC58 etid
- Durham, NC58 etid
- Chicago, IL51 etid
- Atlanta, GA49 etid
- Seattle, WA49 etid
- Arlington, VA48 etid
Lòt etid nan Charlotte
- Kansè nan tete22 etid
- Myelom Miltip21 etid
- Kansè Poumon ki pa ti selil19 etid
- Leksemi mieloïd egi16 etid
- Obèsite16 etid
- Sipwa15 etid
- Kansè kolorektal13 etid
- Kansè ovè12 etid
- Ensifizyans kadyak11 etid
- Kansè Metastatik11 etid
- Karsinòm selil skuamèz tèt ak kou10 etid
- BPCO9 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.